Investor Relations
Key Figures
| IFRS (in EURm except otherwise stated) | 2018 | 2017 |
| Revenues | 3,781.1 | 2,971.4 |
| Adjusted EBITDA | 719.8 | 556.7 |
| Reported EBITDA | 651.4 | 513.2 |
| Adjusted Basic EPS (EUR) | 20.11 | 17.49 |
| Net Operating Cash Flow | 543.9 | 405.1 |
Outstanding shares:
17,799,006 (at 31.08.2019)
Dividend
The AGM of 25 April 2019 approved the payment of a dividend of EUR 2.88 per share for the year 2018 compared to EUR 2.40 for the previous year.
Financial News
- 11.09.2019Eurofins announces the success of its Tender Offer on its 300M€ outstanding hybrid notes with a first call date on 31 January 2020
- 04.09.2019Eurofins successfully prices EUR 300m new hybrid notes
- 03.09.2019Eurofins intends to issue new hybrid notes to replace its 300M€ outstanding hybrid notes with a first call date on 31 January 2020 and to launch a tender offer on those 2020 hybrid notes
- 29.08.2019Eurofins reports robust financial performance in H1 2019 despite disruptions from the June cyber-attack
- 25.06.2019Eurofins Expands its Transplantation Testing Footprint with the Acquisition of Transplant Genomics Inc.
Annual Reports
Next Publication: Q3/NM 2019 Interim Management Statement, 28 October 2019 (TBC)
Sign up to Eurofins' IR distribution list
Eurofins' 20-year IPO value creation study by Marten & Co.
Research Paper by Prof. Brooks
OBSAAR prospectus in French only